These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1360399)
1. Evaluation of a method for detection of cells with reduced drug retention in solid tumours. Carpentier Y; Gorisse MC; Desoize B Cytometry; 1992; 13(6):630-7. PubMed ID: 1360399 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies. Van Acker KL; Van Hove LM; Boogaerts MA Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231 [TBL] [Abstract][Full Text] [Related]
3. Selection of a new multidrug resistant cell line from Friend leukemia cells by short and cyclic exposures to high concentrations of daunorubicin. Abbadessa V; Tolomeo M; Luparello M; Perricone R; Cajozzo A; Dusonchet L; Candiloro V; Crosta L; Rausa L Haematologica; 1992; 77(2):137-41. PubMed ID: 1356894 [TBL] [Abstract][Full Text] [Related]
4. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry. Tapiero H; Fourcade A; Vaigot P; Farhi JJ Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693 [TBL] [Abstract][Full Text] [Related]
5. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A. Gollapudi S; Gupta S Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515 [TBL] [Abstract][Full Text] [Related]
6. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024 [TBL] [Abstract][Full Text] [Related]
7. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells. Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719 [TBL] [Abstract][Full Text] [Related]
8. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric double labeling technique for screening of multidrug resistance. Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985 [TBL] [Abstract][Full Text] [Related]
10. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135 [TBL] [Abstract][Full Text] [Related]
11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
12. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells. Tapiero H; Nguyen-Ba G; Lampidis TJ Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells. Bogush T; Robert J Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637 [TBL] [Abstract][Full Text] [Related]
14. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting. Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281 [TBL] [Abstract][Full Text] [Related]
15. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751 [TBL] [Abstract][Full Text] [Related]
16. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content. Ross DD; Thompson BW; Ordóñez JV; Joneckis CC Cytometry; 1989 Mar; 10(2):185-91. PubMed ID: 2714107 [TBL] [Abstract][Full Text] [Related]
17. Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia. Merlin JL; Marchal S; Ramacci C; Notter D; Vigneron C Int J Hyperthermia; 1995; 11(6):855-65. PubMed ID: 8586906 [TBL] [Abstract][Full Text] [Related]